LI Gu-cai, YIN Duan-zhi, CHENG Deng-feng, XU Wan-bang, ZHENG Ming-qiang, WANG Yong-xian. Biological Evaluation of 18F-FHTP as a Potential Dopamine D4 Receptor PET Imaging Agent[J]. Journal of Nuclear and Radiochemistry, 2008, 30(2): 80-85.
    Citation: LI Gu-cai, YIN Duan-zhi, CHENG Deng-feng, XU Wan-bang, ZHENG Ming-qiang, WANG Yong-xian. Biological Evaluation of 18F-FHTP as a Potential Dopamine D4 Receptor PET Imaging Agent[J]. Journal of Nuclear and Radiochemistry, 2008, 30(2): 80-85.

    Biological Evaluation of 18F-FHTP as a Potential Dopamine D4 Receptor PET Imaging Agent

    • 3-(4-18Ffluorobenzyl)-8-hydroxy-1, 2, 3, 4-tetrahydrochromeno3, 4-c pyridin-5-one (18F-FHTP) was in vitroand in vivoevaluated as a potential dopamine D4 receptor PET imaging agent. Through receptor binding assay, the Kiof FHTP were determined to be 2.9 nmol/L for D4.2 receptor, and to be greater than 3 000 and 5 800 nmol/L for D3 and D2 receptor, respectively. The lgP was measured to be 1.11 through octanol experiment. The regional biodistribution studies in rats were carried out through biological distribution and blocking biodistribution experiments. The biodistributions studies show that 18F-FHTP can penetrate through bloodbrain barrier and selectively accumulate in striatum, hypothalamus, frontal cortex, hippocampus, cerebellum, where the D4 receptor is reportedly located, and among organs, lung and kidney have higher uptakes than the others. Conclusively, in vitro and in vivo biological studies demonstrate that 18F-FHTP is a potential dopamine D4 receptor imaging agent.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return